Tisento Therapeutics
@tisentotx.bsky.social
To those lacking effective treatment options: We hear you. And we are relentlessly driving toward much-needed solutions. #MELAS #MitochondrialDisease
On U.S. Thanksgiving, we want to say thank you to our global community who partner with us on our mission to develop medicines that address what matters most. Thank you to those living with MELAS, their loved ones, advocates, healthcare providers, and our team! #Biosky #Thanksgiving2025
November 27, 2025 at 1:15 PM
On U.S. Thanksgiving, we want to say thank you to our global community who partner with us on our mission to develop medicines that address what matters most. Thank you to those living with MELAS, their loved ones, advocates, healthcare providers, and our team! #Biosky #Thanksgiving2025
Thanks, @MitoCanada, for creating an accessible, community-friendly summary of our interview study with adults who have MELAS! #MitochondrialDisease #MitoInsights #WeHearYou #Biosky mitocanada.org/signs-sympto...
November 20, 2025 at 10:12 PM
Thanks, @MitoCanada, for creating an accessible, community-friendly summary of our interview study with adults who have MELAS! #MitochondrialDisease #MitoInsights #WeHearYou #Biosky mitocanada.org/signs-sympto...
Tomorrow, Chad Glasser, VP of Clinical Research, will present at the Wellcome Mitochondrial Medicine Conference on assessing cognitive function in #PrimaryMitochondrialDisease clinical trials. #MELAS #ClinicalDevelopment #Biosky coursesandconferences.wellcomeconnectingscience.org/event/mitoch...
November 11, 2025 at 12:45 PM
Tomorrow, Chad Glasser, VP of Clinical Research, will present at the Wellcome Mitochondrial Medicine Conference on assessing cognitive function in #PrimaryMitochondrialDisease clinical trials. #MELAS #ClinicalDevelopment #Biosky coursesandconferences.wellcomeconnectingscience.org/event/mitoch...
Findings from our #MELAS interview study were recently published in the Journal of Patient-Reported Outcomes. The study highlighted the symptoms & impacts most important to patients and informed our Phase 2b PRIZM study. #MitochondrialDisease #PRO #Biosky www.tisentotx.com/news/tisento...
November 3, 2025 at 12:16 PM
Findings from our #MELAS interview study were recently published in the Journal of Patient-Reported Outcomes. The study highlighted the symptoms & impacts most important to patients and informed our Phase 2b PRIZM study. #MitochondrialDisease #PRO #Biosky www.tisentotx.com/news/tisento...
Last call for our PRIZM clinical study in #MELAS! We’re expecting to complete enrollment in the next few weeks. Those who are interested in participating at one of our sites around the world can find out more by talking to their doctor. #ClinicalResearch #MitochondrialDisease www.tisentotx.com/prizm
September 25, 2025 at 12:05 PM
Last call for our PRIZM clinical study in #MELAS! We’re expecting to complete enrollment in the next few weeks. Those who are interested in participating at one of our sites around the world can find out more by talking to their doctor. #ClinicalResearch #MitochondrialDisease www.tisentotx.com/prizm
To us, #LightUpForMito is personal. While monuments and landmarks around the world are lit up in green, we’re lighting up our homes, our pets, and ourselves. We stand with the #MitochondrialDisease community! #WorldMitoWeek2025 #DecodeThePuzzle #Biosky
September 20, 2025 at 9:01 PM
To us, #LightUpForMito is personal. While monuments and landmarks around the world are lit up in green, we’re lighting up our homes, our pets, and ourselves. We stand with the #MitochondrialDisease community! #WorldMitoWeek2025 #DecodeThePuzzle #Biosky
Tonight, landmarks, buildings & monuments around the world will light up in GREEN to shine a light on #MitochondrialDiseases. This display raises visibility, sparks conversations & shows solidarity with the mito community. #LightUpForMito #WorldMitoWeek2025 #Biosky mitopatients.org/light-up-for...
September 20, 2025 at 2:30 PM
Tonight, landmarks, buildings & monuments around the world will light up in GREEN to shine a light on #MitochondrialDiseases. This display raises visibility, sparks conversations & shows solidarity with the mito community. #LightUpForMito #WorldMitoWeek2025 #Biosky mitopatients.org/light-up-for...
Your voice matters for those affected by #MitochondrialDisease! International Mito Patients (IMP) has practical tips and useful resources for getting involved during #WorldMitoWeek2025 and beyond! #DecodeTheMitoPuzzle #Biosky mitopatients.org/mito-week/
September 19, 2025 at 12:30 PM
Your voice matters for those affected by #MitochondrialDisease! International Mito Patients (IMP) has practical tips and useful resources for getting involved during #WorldMitoWeek2025 and beyond! #DecodeTheMitoPuzzle #Biosky mitopatients.org/mito-week/
#MELAS can affect multiple organ systems and frequently causes a range of severe and burdensome symptoms. We are working on what could be the first treatment for this devastating disease through our PRIZM MELAS study. #WorldMitoWeek2025 #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky
September 18, 2025 at 1:03 PM
#MELAS can affect multiple organ systems and frequently causes a range of severe and burdensome symptoms. We are working on what could be the first treatment for this devastating disease through our PRIZM MELAS study. #WorldMitoWeek2025 #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky
Collaboration among researchers, clinicians & patients translates science into real-world impact for those with #MitochondrialDisease. We’re proud to be part of this network with our PRIZM #MELAS clinical study. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky www.tisentotx.com/prizm
September 17, 2025 at 11:30 AM
Collaboration among researchers, clinicians & patients translates science into real-world impact for those with #MitochondrialDisease. We’re proud to be part of this network with our PRIZM #MELAS clinical study. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky www.tisentotx.com/prizm
Mitochondria are known as “the powerhouse of the cell,” generating ~90% of the energy our bodies need and playing a critical role in many different bodily systems and organs. #MitochondrialDiseases have broad and debilitating consequences. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky
September 16, 2025 at 3:30 PM
Mitochondria are known as “the powerhouse of the cell,” generating ~90% of the energy our bodies need and playing a critical role in many different bodily systems and organs. #MitochondrialDiseases have broad and debilitating consequences. #WorldMitoWeek2025 #DecodeTheMitoPuzzle #Biosky
#WorldMitoWeek2025 starts today! This advocacy week is intended to raise awareness about #MitochondrialDiseases with a goal of improving the lives of people affected by these diseases. Join us in supporting this global community! #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky
September 15, 2025 at 10:02 AM
#WorldMitoWeek2025 starts today! This advocacy week is intended to raise awareness about #MitochondrialDiseases with a goal of improving the lives of people affected by these diseases. Join us in supporting this global community! #MitochondrialDisease #DecodeTheMitoPuzzle #Biosky
Next week is #WorldMitoWeek2025. We love the theme, #DecodeTheMitoPuzzle, focused on connecting science to lived experiences with #MitochondrialDisease. Our PRIZM #MELAS study is rooted in this approach & is screening now but not for much longer! #WeHearYou #Biosky www.tisentotx.com/prizm
September 9, 2025 at 12:15 PM
Next week is #WorldMitoWeek2025. We love the theme, #DecodeTheMitoPuzzle, focused on connecting science to lived experiences with #MitochondrialDisease. Our PRIZM #MELAS study is rooted in this approach & is screening now but not for much longer! #WeHearYou #Biosky www.tisentotx.com/prizm
We’re on a mission to deliver medicines that address what matters most for people with #MitochondrialDiseases, beginning with MELAS and our Phase 2b PRIZM study. Learn more: www.tisentotx.com/prizm #ClinicalResearch #NowEnrolling #RareDisease
August 25, 2025 at 12:15 PM
We’re on a mission to deliver medicines that address what matters most for people with #MitochondrialDiseases, beginning with MELAS and our Phase 2b PRIZM study. Learn more: www.tisentotx.com/prizm #ClinicalResearch #NowEnrolling #RareDisease
Interested in participating in our Phase 2b PRIZM study for adults with MELAS? We expect to complete enrollment soon, but we are still looking for a few more participants. Reach out right away! www.tisentotx.com/prizm #ClinicalResearch #MitochondrialDisease #RareDisease #Biosky
August 21, 2025 at 3:45 PM
Interested in participating in our Phase 2b PRIZM study for adults with MELAS? We expect to complete enrollment soon, but we are still looking for a few more participants. Reach out right away! www.tisentotx.com/prizm #ClinicalResearch #MitochondrialDisease #RareDisease #Biosky
Our #MELAS open-label extension study has officially started! The first participant is now enrolled after completing treatment in our global Phase 2b PRIZM study. PRIZM is actively enrolling and expected to complete screening in the next months. #Biosky www.tisentotx.com/news/first-p...
August 20, 2025 at 11:09 AM
Our #MELAS open-label extension study has officially started! The first participant is now enrolled after completing treatment in our global Phase 2b PRIZM study. PRIZM is actively enrolling and expected to complete screening in the next months. #Biosky www.tisentotx.com/news/first-p...
We’re so proud of Hannah Milne, who is training for the #ChicagoMarathon and fundraising for the United Mitochondrial Disease Foundation! Hannah is the daughter of our chief operating officer Todd Milne and is proud to run this race on behalf of #TeamTisento. #Biosky give.umdf.org/fundraiser/6...
August 7, 2025 at 9:42 PM
We’re so proud of Hannah Milne, who is training for the #ChicagoMarathon and fundraising for the United Mitochondrial Disease Foundation! Hannah is the daughter of our chief operating officer Todd Milne and is proud to run this race on behalf of #TeamTisento. #Biosky give.umdf.org/fundraiser/6...
#DidYouKnow: International Mito Patients (IMP) is a network of 18 patient organizations, spanning 3 continents, that support people with #MitochondrialDiseases globally. IMP also supports people living in countries without a national mito organization. #Biosky mitopatients.org/members/
July 31, 2025 at 10:45 AM
#DidYouKnow: International Mito Patients (IMP) is a network of 18 patient organizations, spanning 3 continents, that support people with #MitochondrialDiseases globally. IMP also supports people living in countries without a national mito organization. #Biosky mitopatients.org/members/
Living with #MitochondrialDisease? Beat the heat this summer with these useful tips from #MitoAction! Be sure to consult with your doctor as well. #Biosky www.mitoaction.org/day-to-day-w...
July 23, 2025 at 2:31 PM
Living with #MitochondrialDisease? Beat the heat this summer with these useful tips from #MitoAction! Be sure to consult with your doctor as well. #Biosky www.mitoaction.org/day-to-day-w...
#ICYMI: Tune into the #MitoAction “Energy in Action” podcast to hear about our PRIZM Phase 2 study in MELAS, how patient interviews helped shape the study, and our commitment to listening to patients. #MitochondrialDisease #RareDisease #ClinicalResearch #Biosky bit.ly/3I7Hp3V
June 30, 2025 at 6:01 PM
#ICYMI: Tune into the #MitoAction “Energy in Action” podcast to hear about our PRIZM Phase 2 study in MELAS, how patient interviews helped shape the study, and our commitment to listening to patients. #MitochondrialDisease #RareDisease #ClinicalResearch #Biosky bit.ly/3I7Hp3V
At #MitoMed? Stop by the Research Pavilion to check out the mitoARCH (Mitochondrial All-Comers Research on Cognitive Health) study! We’re hoping to unearth new insights about the impact of cognitive health in #MitochondrialDisease. #Biosky @UMDF umdfconference.org/clinical-res...
June 19, 2025 at 3:59 PM
At #MitoMed? Stop by the Research Pavilion to check out the mitoARCH (Mitochondrial All-Comers Research on Cognitive Health) study! We’re hoping to unearth new insights about the impact of cognitive health in #MitochondrialDisease. #Biosky @UMDF umdfconference.org/clinical-res...
#MitoMed 2025 starts today! We’re looking forward to discussing the latest developments in #MitochondrialMedicine and connecting with researchers, healthcare providers, patients, and families from around the world. Stop by our booth! #Biosky
June 18, 2025 at 4:32 PM
#MitoMed 2025 starts today! We’re looking forward to discussing the latest developments in #MitochondrialMedicine and connecting with researchers, healthcare providers, patients, and families from around the world. Stop by our booth! #Biosky
We’re excited to share that our investigational, once-daily, oral medicine has been granted Fast Track designation by @fda.gov for the treatment of MELAS! #MitochondrialDisease #RareDisease #ClinicalDevelopment #Biosky www.tisentotx.com/news/tisento...
June 17, 2025 at 11:08 AM
We’re excited to share that our investigational, once-daily, oral medicine has been granted Fast Track designation by @fda.gov for the treatment of MELAS! #MitochondrialDisease #RareDisease #ClinicalDevelopment #Biosky www.tisentotx.com/news/tisento...
Thanks to #MitoAction for having us on the “Energy in Action” podcast! Tune in to learn about our PRIZM MELAS study, our lead compound, and our commitment to listening to patients. #MitochondrialDisease #RareDisease #ClinicalResearch #Biosky energy-in-action-by-mitoaction.castos.com/episodes/how...
June 12, 2025 at 8:06 PM
Thanks to #MitoAction for having us on the “Energy in Action” podcast! Tune in to learn about our PRIZM MELAS study, our lead compound, and our commitment to listening to patients. #MitochondrialDisease #RareDisease #ClinicalResearch #Biosky energy-in-action-by-mitoaction.castos.com/episodes/how...
Attending #MitoMed 2025 and interested in contributing to #ClinicalResearch in #MitochondrialMedicine? Consider participating in the mitoARCH study, which is designed to better understand the impact of primary #MitochondrialDisease (PMD) on cognition. umdfconference.org/clinical-res...
June 2, 2025 at 1:06 PM
Attending #MitoMed 2025 and interested in contributing to #ClinicalResearch in #MitochondrialMedicine? Consider participating in the mitoARCH study, which is designed to better understand the impact of primary #MitochondrialDisease (PMD) on cognition. umdfconference.org/clinical-res...